心肌造影剂摄取与冠状动脉疾病及预后的关系
该研究回顾性分析457例在左心室造影前12个月内行冠状动脉造影的患者,评估心肌造影剂摄取(MCU)模式对冠状动脉疾病的诊断效能及预后价值。MCU检测冠状动脉疾病的敏感度为87.6%、特异度为75.5%,阳性预测值73.0%、阴性预测值87.7%。中位随访17.3个月发生52例事件,替代型、间质型和心内膜下MCU模式均与事件相关。
要点
- 左心室造影时观察到的MCU对冠状动脉疾病有较高敏感度(87.6%)和阴性预测值(87.7%)。
- MCU分为替代型和间质型,其中心内膜下模式需进一步观察。
- 替代型、间质型和心内膜下MCU模式均与不良临床事件相关。
核心结论
- MCU的存在有助于识别冠状动脉疾病,并对临床结局提供增量预后价值。
- 替代型、间质型和心内膜下MCU模式均与事件相关。
研究设计与样本
- 回顾性分析457例在左心室造影前12个月内行冠状动脉造影的已知或疑似冠状动脉疾病患者。
- 对造影超声心动图进行分析,将MCU分类为替代型或间质型,并进一步观察心内膜下模式。
- 主要复合事件定义为急性冠状动脉综合征、心力衰竭住院、持续性室性心动过速和全因死亡的发生。
关键影像表现/征象
- 左心室造影期间频繁观察到心肌造影剂摄取(MCU)。
- MCU模式分为替代型和间质型,其中心内膜下模式需进一步观察。
诊断标准与关键数值
- MCU检测冠状动脉疾病的敏感度为87.6%、特异度为75.5%、阳性预测值为73.0%、阴性预测值为87.7%。
- 中位随访17.3个月,共发生52例事件。
临床应用与阅片要点
- 在左心室造影时注意观察心肌造影剂摄取及其模式(替代型、间质型、心内膜下型)。
- MCU的存在可用于辅助识别冠状动脉疾病,并可能提供预后信息。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
During left ventricular opacification (LVO), myocardial contrast uptake (MCU) is frequently observed, but its clinical implication is uncertain. We aimed to investigate the diagnostic performance of MCU and its prognostic value in known or suspected coronary artery disease (CAD). Contrast echocardiography was retrospectively analyzed in 457 patients who had previous coronary angiography <12 mo before LVO. MCU was classified into replacement or interstitial patterns. Subendocardial patterns were further inspected. Events were defined as a primary composite of the occurrence of acute coronary syndrome, heart failure hospitalization, sustained ventricular tachycardia and all-cause mortality. MCU had an 87.6% sensitivity, 75.5% specificity, 73.0% positive predictive value and 87.7% negative predictive value in detecting CAD. After a median follow-up of 17.3 mo, 52 events occurred. Replacement, interstitial and subendocardial MCU patterns were associated with events. In conclusion, the presence of MCU was useful in identifying CAD and provided incremental prognostic value for clinical outcomes.
引用
- Kim H, Kim IC, Lee CH, et al. Myocardial Contrast Uptake in Relation to Coronary Artery Disease and Prognosis. Ultrasound Med Biol. 2020. PMID: 32439357. doi:10.1016/j.ultrasmedbio.2020.04.012
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。